- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Renalytix AI plc (RENX)
Renalytix AI plc stock price live, this page displays LON RENX stock exchange data. View the RENX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Renalytix AI plc real time stock price chart below.
What Is the Renalytix AI plc Stock Price Today?
The Renalytix AI plc stock price today is 7.50.
What Is the Stock Symbol for Renalytix AI plc?
The stock symbol for Renalytix AI plc is ""RENX.""
What Stock Exchange Does Renalytix AI plc Trade On?
Renalytix AI plc is listed and trades on the London stock exchange.
Is Renalytix AI plc a Good Stock to Buy?
Determining whether Renalytix AI plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RENX quote. (ISIN: GB00BYWL4Y04)
What Is the Renalytix AI plc Stock Price Today?
The Renalytix AI plc stock price today is 7.50.
What Is the Stock Symbol for Renalytix AI plc?
The stock symbol for Renalytix AI plc is ""RENX.""
What Stock Exchange Does Renalytix AI plc Trade On?
Renalytix AI plc is listed and trades on the London stock exchange.
Is Renalytix AI plc a Good Stock to Buy?
Determining whether Renalytix AI plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RENX quote. (ISIN: GB00BYWL4Y04)
7.50
0.00(0.00%)
Closed·
Fair Value
An estimate of a Renalytix AI's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.10
8.00
52 wk Range
0.07
15.00
RENX Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
RENX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Renalytix AI's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.108.00
52 wk Range
0.0715.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
RENX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Renalytix AI's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Renalytix AI plc Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. It has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. The company was incorporated in 2018 and is based in New York, New York.
Renalytix AI plc Earnings Call Summary for Q2/2025
- Q4 2024 EPS missed at -0.05 vs -0.015 forecast; revenue beat at $1.25M vs $1M expected
- Stock fell 2.22% post-earnings; company aims for 1% US market penetration in 3-4 years
- Revenue projected at $3.2M for FY2025, $8.4M for FY2026; analysts maintain Strong Buy consensus
- Kidney IntellX remains key product with Medicare reimbursement; focus on preventative medicine
- Financial Health Score of 1.3 indicates challenges; cash position at $9.2M provides foundation
Last Updated: 18/03/2025, 16:36
Read Full TranscriptCompare RENX to Peers and Sector
Metrics to compare | RENX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRENXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.2x | −0.8x | −0.5x | |
PEG Ratio | −0.02 | 0.07 | 0.00 | |
Price/Book | −24.4x | 1.5x | 2.6x | |
Price / LTM Sales | 11.5x | 1.6x | 3.3x | |
Upside (Analyst Target) | - | 40.9% | 43.4% | |
Fair Value Upside | Unlock | 11.1% | 7.1% | Unlock |
Earnings
Latest Release
Jun 17, 2025
EPS / Forecast
-- / -0.015
Revenue / Forecast
-- / 1.20M
FAQ
What Stock Exchange Does Renalytix AI Trade On?
Renalytix AI is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Renalytix AI?
The stock symbol for Renalytix AI is "RENX."
What Is the Renalytix AI Market Cap?
As of today, Renalytix AI market cap is 24.84M.
What Is Renalytix AI's Earnings Per Share (TTM)?
The Renalytix AI EPS (TTM) is -0.22.
When Is the Next Renalytix AI Earnings Date?
Renalytix AI will release its next earnings report on 03 Nov 2025.
From a Technical Analysis Perspective, Is RENX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Renalytix AI Stock Split?
Renalytix AI has split 0 times.
How Many Employees Does Renalytix AI Have?
Renalytix AI has 102 employees.
What is the current trading status of Renalytix AI (RENX)?
As of 10 Aug 2025, Renalytix AI (RENX) is trading at a price of 7.50, with a previous close of 7.50. The stock has fluctuated within a day range of 7.10 to 8.00, while its 52-week range spans from 0.07 to 15.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.